This special edition of JOPON features foundational work done by the Children's Oncology Group (COG) Nursing Discipline to address symptom assessment in children undergoing treatment for cancer. Symptom assessment lays the groundwork for understanding illness-related distress, a key gap in knowledge currently being confronted by the COG Nursing Discipline (Landier, Leonard, & Ruccione, 2013) . Approximately 80% of children treated for cancer experience treatmentassociated symptoms, such as fatigue, pain, nausea, and sleep disturbances, with each child on average experiencing 10 symptoms during their cancer treatment (Baggott et al., 2010; Buckner et al., 2014; Hockenberry et al., 2010) . Despite the high prevalence of treatment-related symptoms in children with cancer, there is currently no standardized approach for symptom assessment and management in pediatric oncology.
In October 2018, a State of the Science Symposium (R13CA232442 Rodgers/Hockenberry) was convened to develop expert consensus regarding the major symptoms experienced during childhood cancer treatment, the appropriate observational and biological measures to assess these symptoms, and key strategies necessary for consistent symptom assessment throughout the illness trajectory. This consensus conference, "Symptom Assessment During Childhood Cancer Treatment: State of the Science Symposium" was attended by 90 interprofessional participants representing 56 COG institutions; registration was limited to allow for strategic interactions between invited experts and participants.
This edition of JOPON features articles developed from the Symposium proceedings, including In his remarks at the State of the Science Symposium, Dr. Peter Adamson, Chair of the Children's Oncology Group, highlighted the important work of his mentor, Dr. Giulio D'Angio, the renowned pediatric radiation oncologist, who in the early days of pediatric oncology famously cautioned childhood cancer professionals that "cure is not enough" (D'Angio, 1975) . In fact, Dr. D'Angio warned that "every treatment has its undesirable side effects, some minor, some major" (D'Angio, 1975 ). In the current era, when 5-year survival rates for childhood cancer now exceed 80% (Siegel, Miller, & Jemal, 2019) , it is even more important for us to focus on standardizing symptom assessment, the foundational first step necessary for improving symptom management for pediatric oncology patients throughout their cancer journey.
Finally, we would like to dedicate this issue of JOPON in memory of Cheryl C. Rodgers, PhD, RN, CPNP, CPON, FAAN, whose untimely death in July 2018 cut short a life full of promise, vision, and significant accomplishments. Dr. Rodgers's program of research was dedicated to improving symptom management in pediatric oncology. She led the effort and secured the funding for the Symposium reported here, and it is to honor her legacy that we and our many colleagues in pediatric oncology nursing are doubling our efforts to assure that the important work that Dr. Rogers envisioned is carried out. In one of the last interactions we had with Dr. Rogers, she presciently declared, "I hope that pediatric oncology nurses will not accept the status quo when providing care to their patients, but instead, start asking questions about best nursing 
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